Malignant Carcinoid

Download PDF

Recent Publications on Malignant Carcinoid:
Scleroderma-like disorders. Fibrosing disorders comprise a wide spectrum of heterogeneous diseases...	17th July, 2008	Rheumatology Unit, Azienda Ospedaliera Universitaria V. Emanuele,	Autoimmun Rev. 2008 Feb;7(4):331-9. Epub 2008 Jan 11. DOI Direct Link
Reversible parkinsonism and ataxia associated with high-dose octreotide. The patient--born in 1960, was first diagnosed in 1981 as having malignant...	3rd July, 2008	Department of Neurology, University of Cincinnati, 231 Albert Sabin Way,	Neurology. 2008 Jun 10;70(24):2345-6. Epub 2008 May 7. DOI Direct Link
[Somatostatin analogues in the treatment of carcinoid] The patient--born in 1960, was first diagnosed in 1981 as having malignant...	27th June, 2008	Klinika komplexni onkologicke pece, Masarykuv, onkologicky ustav, Brno.	Cas Lek Cesk. 2008;147(4):233-5.
High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss. Carcinoid tumors of the small intestine are characterized by an indolent...	27th June, 2008	Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA,	Genes Chromosomes Cancer. 2008 Jul;47(7):591-603. DOI Direct Link
Carcinoid syndrome with angioedema and urticaria. The patient--born in 1960, was first diagnosed in 1981 as having malignant...	25th June, 2008		Arch Dermatol. 2008 May;144(5):691-2. DOI Direct Link
→View more research publications.

Malignant Carcinoid Clinical Trials:
Study to Evaluate the Efficacy and Safety of 90Y-SMT487 in Subjects With Symptomatic Malignant Carcinoid Tumors	Malignant Carcinoid Tumor

Malignant Carcinoid Patents:
US Patent No.	Title
7053117	Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
7138370	Specific binding agents of human angiopoietin-2
7144873	Kit for delivering decitabine in vivo
7144876	3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
7154002	Histone deacetylase inhibitors
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Malignant Carcinoid scientists - we have details of around 177 individuals working on Malignant Carcinoid .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.